Orvepitant Maleate ( DrugBank: Orvepitant )


1 disease
IDDisease name (Link within this page)Number of trials
85Idiopathic interstitial pneumonia1

85. Idiopathic interstitial pneumonia


Clinical trials : 627 Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05185089
(ClinicalTrials.gov)
August 1, 202223/12/2021Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary FibrosisA Double-Blind, Randomised, Placebo Controlled, Two Period Cross-Over Study to Evaluate the Efficacy and Safety of Orvepitant in Chronic Cough in Patients With Idiopathic Pulmonary FibrosisCough;Idiopathic Pulmonary FibrosisDrug: Orvepitant Maleate;Drug: PlaceboNerre Therapeutics Ltd.Pharm-Olam InternationalRecruiting40 YearsN/AAll88Phase 2United States;Netherlands;United Kingdom